Home » Topics » Conferences

Conferences
RSS

Invitation to access the ongoing telesymposium on rheumatoid arthritis therapies

July 17, 1998

Venlafaxine relieves anxiety; more cost-effective than other antidepressants

July 16, 1998

LG-120907, a potent antiandrogen with reduced adverse effects

July 16, 1998

Risperidone: satellite symposia discuss impact on cognition and behavior

July 16, 1998

M-100907 improves positive and negative symptoms and is well tolerated in schizophrenics

July 15, 1998

Preliminary evidence of antidepressant effect for igmesine, a sigma ligand

July 15, 1998

Spotlight on estrone sulfatase inhibitors for treatment of breast cancer

July 14, 1998

EM-800, a more potent antiestrogen than raloxifene in preclinical studies

July 14, 1998

New evidence supports the efficacy of PKC inhibition in diabetic neuropathy

July 14, 1998

Vitamin D analogue EB-1089 acts via effects on IGF-I

July 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...